Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2015

Jun 2, 2015

32870_dirs_2015-06-02_af097052-145a-4561-bb5f-f26ec8079534.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-06-01

Reporting Person: Havey Adam (EVP, Biodefense Divison)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-01 Common Stock P 98 $27.08 Acquired 41444 Direct

Footnotes

F1: Consists of shares acquired under the Emergent BioSolutions Employee Stock Purchase Plan.